Cargando…
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554400/ https://www.ncbi.nlm.nih.gov/pubmed/26345514 http://dx.doi.org/10.2147/IJN.S87133 |
Ejemplares similares
-
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia
por: Hoggatt, Jonathan, et al.
Publicado: (2015) -
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
por: Guariglia, Roberto, et al.
Publicado: (2016) -
Meta-analysis and indirect treatment comparison of lipegfilgrastim
with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced
neutropenia-related events
por: Bond, T Christopher, et al.
Publicado: (2017) -
Review on lipegfilgrastim
por: Gasparic, Maja, et al.
Publicado: (2015) -
Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer
por: Akpo, Esse I. H., et al.
Publicado: (2017)